Skip to main content
Top
Published in:

Open Access 13-03-2025 | Radiotherapy | Review

Radiation-induced lung injury: from mechanism to prognosis and drug therapy

Authors: Sheng Wang, Duo Xu, Lingyan Xiao, Bo Liu, Xianglin Yuan

Published in: Radiation Oncology | Issue 1/2025

Login to get access

Abstract

Radiation induced lung injury, known as the main complication of thoracic radiation, remains to be a major resistance to tumor treatment. Based on the recent studies on radiation-induced lung injury, this review collated the possible mechanisms at the level of target cells and key pathways, corresponding prognostic models including predictors, patient size, number of centers, radiotherapy technology, construction methods and accuracy, and pharmacotherapy including drugs, targets, therapeutic effects, impact on anti-tumor treatment and research types. The research priorities and limitations are summarized to provide a reference for the research and management of radiation-induced lung injury.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Radiation-induced lung injury: from mechanism to prognosis and drug therapy
Authors
Sheng Wang
Duo Xu
Lingyan Xiao
Bo Liu
Xianglin Yuan
Publication date
13-03-2025
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2025
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-025-02617-8

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more